Skip to content
value.today
Total raised
$209 M
4 rounds on record
Latest round
$69 M
Aug 2020
First round on record
Aug 2011
Today
Went public
See the company page

NeuroPace Inc is listed today as NeuroPace, Inc.: market value, financials and filings are on its company page.

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of NeuroPace Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2020$69 MNo. 4$50 to $250 million

NeuroPace Inc: Raise no. 4, Aug 2020

Investors in this round

23 investors had bought by the notice of Aug 31, 2020: 23 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for NeuroPace Inc as a whole in other filings: see Investors below.

What the notice says

Amount sold
$69 M of $96 M offered; $27 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: (i) Series B' Preferred Stock; Common Stock issuable upon conversion
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$663,428
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Frank Fischer · Executive Officer, Director
  • Mike Favet · Executive Officer, Director
  • Rebecca Kuhn · Executive Officer
  • Evan Norton · Director
  • Greg Garfield · Director
  • Joseph Lacob · Director
  • Nael Kassar · Director
  • Renee Ryan · Director
  • Rishi Gupta · Director
  • Vince Burgess · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Offering Amount includes conversion of outstanding indebtedness in the amount of $36,385,617.25.”
  • On the use of proceeds: “Proceeds will be used for general corporate purposes including, but not limited to, executive salaries”

Signed by Rebecca Kuhn, VP, Finance & Administration. Source: SEC Form D, newest notice filed Aug 31, 2020. Read the notice at the SEC.

equitySEC
Sep 2016$72 MNo. 3$50 to $250 million

NeuroPace Inc: Raise no. 3, Sep 2016

Investors in this round

26 investors had bought by the notice of Aug 8, 2017: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for NeuroPace Inc as a whole in other filings: see Investors below.

What the notice says

Amount sold
$72 M of $80 M offered; $8 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: (i) Series A' Preferred Stock; Common Stock issuable upon conversion
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Frank Fischer · Executive Officer, Director
  • Rebecca Kuhn · Executive Officer
  • Greg Garfield · Director
  • Jonathan Silverstein · Director
  • Joseph Lacob · Director
  • Mike Favet · Director
  • Nael Kassar · Director
  • Ray Larkin · Director
  • Renee Ryan · Director
  • Vince Burgess · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for general corporate purposes including, but not limited to, executive salaries”

Signed by Rebecca Kuhn, CFO and VP, Finance & Administration. Source: SEC Form D and 1 amendment, newest notice filed Aug 8, 2017. Read the notice at the SEC.

equitySEC
Jul 2013$18 MNo. 2$10 to $50 million

NeuroPace Inc: Raise no. 2, Jul 2013

Investors in this round

20 investors had bought by the notice of Jul 9, 2013: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for NeuroPace Inc as a whole in other filings: see Investors below.

What the notice says

Amount sold
$18 M of $50 M offered; $32 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: (i) Series I Preferred Stock; Common Stock issuable upon conversion and (ii) Series H-2 Preferred Stock; Series H Preferred Stock issuable upon conversion and Common Stock issuable upon conversion
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Debra Smolley · Executive Officer
  • Frank Fischer · Executive Officer, Director
  • Isabella Abati · Executive Officer
  • Martha Morrell · Executive Officer
  • Rebecca Kuhn · Executive Officer
  • Benjamin Pless · Director
  • Chuck Newhall · Director
  • David Fischell · Director
  • James Blair · Director
  • Joseph Lacob · Director
  • Ray Larkin · Director
  • Renee Ryan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for general corporate purposes including, but not limited to, executive salaries”

Signed by Rebecca Kuhn, CFO, VP Fin & Admin and Asst Secy. Source: SEC Form D, newest notice filed Jul 9, 2013. Read the notice at the SEC.

equitySEC
Aug 2011$49 MNo. 1$10 to $50 million

NeuroPace Inc: Raise no. 1, Aug 2011

Investors in this round

22 investors had bought by the notice of Aug 30, 2011: 22 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for NeuroPace Inc as a whole in other filings: see Investors below.

What the notice says

Amount sold
$49 M of $62 M offered; $13 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Debra Smolley · Executive Officer
  • Frank Fischer · Executive Officer, Director
  • Isabella Abati · Executive Officer
  • Martha Morrell · Executive Officer
  • Rebecca Kuhn · Executive Officer
  • Benjamin Pless · Director
  • Brad Vale · Director
  • Chuck Newhall · Director
  • David Fischell · Director
  • James Blair · Director
  • Joseph Lacob · Director
  • Ray Larkin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Rebecca Kuhn, VP Finance & Administration. Source: SEC Form D, newest notice filed Aug 30, 2011. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • NeuroPace Inc chose not to state its revenue in its newest notice of a funding round (Aug 2020).

    SEC Form D · Aug 2020

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Aug 2020

That is all the official record says: NeuroPace Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of NeuroPace Inc are on record.

Investors#

5 named in official filings. Open an investor to see everything it has backed.

Investors in NeuroPace Inc
InvestorKindAmountRoundRoleSource
Accelmed Partners II L.P.Fund or asset managernot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2021)SEC Form 3
Frank M. FischerPersonnot statednot statedHeld Series A and B preferred stock, director (Form 3, 2021)SEC Form 3
KCK LTD.Companynot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2021)SEC Form 3
Orbimed Advisors LLCFund or asset managernot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2021)SEC Form 3
OrbiMed Capital GP VI LLCFund or asset managernot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2021)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 26 investors.

Largest shareholders today

Institutions holding NeuroPace, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by NeuroPace Inc
NameRoleNamed in
Frank FischerExecutive officerAug 2020
Mike FavetExecutive officerAug 2020
Rebecca KuhnExecutive officerAug 2020
Debra SmolleyExecutive officerJul 2013
Isabella AbatiExecutive officerJul 2013
Martha MorrellExecutive officerJul 2013
Evan NortonDirectorAug 2020
Frank FischerDirectorAug 2020
Greg GarfieldDirectorAug 2020
Joseph LacobDirectorAug 2020
Mike FavetDirectorAug 2020
Nael KassarDirectorAug 2020
Renee RyanDirectorAug 2020
Rishi GuptaDirectorAug 2020
Vince BurgessDirectorAug 2020
Jonathan SilversteinDirectorAug 2017
Ray LarkinDirectorAug 2017
Benjamin PlessDirectorJul 2013
Chuck NewhallDirectorJul 2013
David FischellDirectorJul 2013
James BlairDirectorJul 2013
Brad ValeDirectorAug 2011

About

NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation..

Went public since 2021. Its SEC number is that of a company listed on a stock exchange.